deltatrials

Breast cancer Trials in Fano, Italy

Conditions / Breast cancer / Fano, Italy

Breast cancer has been the subject of sustained clinical investigation across multiple research sites.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID Title Status Phase
NCT06757634 Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) RECRUITING PHASE3
NCT00528567 BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer COMPLETED PHASE3
NCT05599334 A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib COMPLETED
NCT00296010 Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer TERMINATED PHASE3
NCT01152606 A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin COMPLETED
NCT01358877 A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer COMPLETED PHASE3
NCT02918084 CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT03439046 Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant COMPLETED PHASE3
NCT02120417 A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer TERMINATED PHASE2
NCT02941926 Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC COMPLETED PHASE3

Related Pages